ArtemiC™ being greenlit as a commercial product without the need for successful phase 3 results is why. It's essentially sky rocketing the value of this company about 6 months in advance of those results! Excellent work by MGC.
Great time to top up right now. Staying clear of Kanabo, seems difficult to ascertain the real value of it, whilst this still seems like a steal in the 3-5p range....
So close to cracking 55p, which will be a high since the decline last year. That seems to be the resistance line for this to have a mini breakthrough. Would love to see 60, or even 70s by the end of March.